Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication
- PMID: 25503625
- PMCID: PMC4335998
- DOI: 10.1212/WNL.0000000000001168
Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication
Abstract
Objectives: To test the effects of pregabalin on the induction of neurogenic claudication.
Methods: This study was a randomized, double-blind, active placebo-controlled, 2-period, crossover trial. Twenty-nine subjects were randomized to receive pregabalin followed by active placebo (i.e., diphenhydramine) or active placebo followed by pregabalin. Each treatment period lasted 10 days, including a 2-step titration. Periods were separated by a 10-day washout period, including a 3-day taper phase after the first period. The primary outcome variable was the time to first moderate pain symptom (Numeric Rating Scale score ≥4) during a 15-minute treadmill test (Tfirst). Secondary outcome measures included pain intensity at rest, pain intensity at the end of the treadmill test, distance walked, and validated self-report measures of pain and functional limitation including the Roland-Morris Disability Questionnaire, modified Brief Pain Inventory-Short Form, Oswestry Disability Index, and Swiss Spinal Stenosis Questionnaire.
Results: No significant difference was found between pregabalin and active placebo for the time to first moderate pain symptom (difference in median Tfirst = -1.08 [95% confidence interval -2.25 to 0.08], p = 0.61). In addition, none of the secondary outcome measures of pain or functional limitation were significantly improved by pregabalin compared with active placebo.
Conclusions: Pregabalin was not more effective than active placebo in reducing painful symptoms or functional limitations in patients with neurogenic claudication associated with lumbar spinal stenosis.
Classification of evidence: This study provides Class I evidence that for patients with neurogenic claudication, compared with diphenhydramine, pregabalin does not increase the time to moderate pain during a treadmill test.
© 2014 American Academy of Neurology.
Figures
Similar articles
-
A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis.Spine (Phila Pa 1976). 2015 May 15;40(10):684-91. doi: 10.1097/BRS.0000000000000837. Spine (Phila Pa 1976). 2015. PMID: 25705958 Clinical Trial.
-
Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.Arthritis Care Res (Hoboken). 2012 Apr;64(4):597-606. doi: 10.1002/acr.21595. Arthritis Care Res (Hoboken). 2012. PMID: 22232085 Clinical Trial.
-
Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.Clin Ther. 2011 Feb;33(2):159-66. doi: 10.1016/j.clinthera.2011.02.007. Epub 2011 Mar 27. Clin Ther. 2011. PMID: 21444113 Clinical Trial.
-
[Pregabalin ineffective in neurogenic claudication symptoms].Praxis (Bern 1994). 2015 Mar 25;104(7):373-4. doi: 10.1024/1661-8157/a001965. Praxis (Bern 1994). 2015. PMID: 25804781 Clinical Trial. German. No abstract available.
-
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.J Pain. 2010 May;11(5):462-71. doi: 10.1016/j.jpain.2009.09.003. Epub 2009 Dec 3. J Pain. 2010. PMID: 19962354 Clinical Trial.
Cited by
-
A Meta-analysis Exploring the Efficacy of Neuropathic Pain Medication for Low Back Pain or Spine-Related Leg Pain: Is Efficacy Dependent on the Presence of Neuropathic Pain?Drugs. 2024 Oct 26:10.1007/s40265-024-02085-6. doi: 10.1007/s40265-024-02085-6. Online ahead of print. Drugs. 2024. PMID: 39455546 Free PMC article.
-
Predictors of success of pharmacological management in patients with chronic lower back pain: systematic review.J Orthop Surg Res. 2024 Apr 18;19(1):248. doi: 10.1186/s13018-024-04741-9. J Orthop Surg Res. 2024. PMID: 38637804 Free PMC article.
-
Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis.Front Pharmacol. 2023 Nov 29;14:1249478. doi: 10.3389/fphar.2023.1249478. eCollection 2023. Front Pharmacol. 2023. PMID: 38094885 Free PMC article.
-
Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study.Pain Ther. 2022 Dec;11(4):1195-1214. doi: 10.1007/s40122-022-00410-z. Epub 2022 Jul 20. Pain Ther. 2022. PMID: 35857196 Free PMC article.
-
Non-operative treatment for lumbar spinal stenosis with neurogenic claudication: an updated systematic review.BMJ Open. 2022 Jan 19;12(1):e057724. doi: 10.1136/bmjopen-2021-057724. BMJ Open. 2022. PMID: 35046008 Free PMC article.
References
-
- Porter RW. Spinal stenosis and neurogenic claudication. Spine 1996;21:2046–2052. - PubMed
-
- Ciol MA, Deyo RA, Howell E, Kreif S. An assessment of surgery for spinal stenosis: time trends, geographic variations, complications, and reoperations. J Am Geriatr Soc 1996;44:285–290. - PubMed
-
- Onel D, Sari H, Donmez C. Lumbar spinal stenosis: clinical/radiologic therapeutic evaluation in 145 patients—conservative treatment or surgical intervention? Spine 1993;18:291–298. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials